# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Bob Marley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML027-SYN
- Date: 2026-07-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Desmond Clarke, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review two weeks after excision of the toenail unit and sentinel node biopsy. **S**

## History of present illness

Mr. Marley returns two weeks after digit-sparing en bloc excision of the nail unit of his right great toe, with a full-thickness skin graft from the inner upper arm and a right inguinal sentinel node biopsy, as a day case. The tie-over dressing came off at one week and the graft had taken. He took acetaminophen for nine days and needs nothing now. He walks in the stiff-soled postoperative shoe and has kept the foot raised when resting. The groin wound is comfortable, with no swelling. The final pathology is back. He has had no thoughts of self-harm. **S**

| Element | Detail |
|---|---|
| Operation | Digit-sparing excision of the nail unit, full-thickness skin graft, and right inguinal sentinel node biopsy, as a day case |
| Pathology | No residual invasive melanoma; margins clear (closest 6 mm); both sentinel nodes negative |
| Final stage | pT1b pN0(sn) M0, pathologic stage IA |
| Recovery | Graft taken; walking in a postoperative shoe; no pain medicine |
| Plans | Wants to run and play football again, and to tour later in the year |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever |
| Musculoskeletal | Positive | Toe stiff and tender when walking far; no other pain |
| Integumentary | Negative | Graft and donor site healing; no discharge |
| Hematologic and lymphatic | Negative | No groin swelling or leg swelling |
| Psychiatric | Negative | Relieved by the result; PHQ-2 score 0 |

5 systems reviewed. **S**

## Current medications

- No current medications. **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/72 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 65.4 kg; BMI 22.6 kg/m². All vital signs are synthetic.

Pain, worst in the past week (0 to 10): 2; PHQ-2: 0. All results are synthetic.

## Change since baseline

- Pain, worst in the past week (0 to 10): 1 at baseline, 2 at this visit **S**
- PHQ-2: 0 at baseline, 0 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 116/72, pulse 66; weight 65.4 kg |
| Right great toe | Graft about 95 percent taken, pink and adherent, with a small area of superficial crusting at the tip; no infection; toe movement nearly full |
| Right groin | Incision healed; no seroma or swelling |
| Right arm | Donor site on the inner upper arm healing in a straight line |
| Extremities | No leg swelling |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acral lentiginous melanoma of the right great toe, pathologic stage IA (pT1b pN0(sn) M0), after digit-sparing excision** (C43.71). The excision is complete with clear margins and no residual invasive melanoma, and both sentinel nodes are negative: pathologic stage IA, with an excellent outlook. Adjuvant immunotherapy or targeted therapy is not indicated at stage IA; it is considered from stage IIB. The toe has been kept, as he chose, without compromising the cancer treatment. Surveillance is by history and examination, with no routine scans or blood tests. **S**
   - No adjuvant therapy.
   - Surveillance: history and examination of the skin, nails, graft and nodes every 6 to 12 months for 5 years, then yearly; a first review at about three months to check the graft; a yearly full skin examination by dermatology.
   - Graft check by the surgical team at six weeks; running once the graft has fully healed, and football after that check.
   - Monthly skin self-examination taught today.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Final pathology of the excision and sentinel nodes | After definitive surgery | Completed today | No residual invasive melanoma; margins clear, closest 6 mm; 0 of 2 sentinel nodes involved |
| Laboratory | AJCC 8th edition pathologic stage | After definitive surgery | Completed today | pT1b pN0(sn) M0, stage IA |
| Medication safety | Adjuvant systemic therapy | Considered from stage IIB | Not indicated | Stage IA |
| Examination | Graft, donor site, and groin wound | Each visit until healed | Completed today | Graft 95 percent taken; groin and arm healing; no infection or seroma |
| Examination | Examination of the lymph node basins (right popliteal and inguinal) and the scar | At diagnosis, then at each surveillance visit | Completed today | No nodes; groin scar healed |
| Imaging | Imaging (CT, PET, or ultrasound) and LDH | Not routine for stage I to II without symptoms | Not indicated | Stage IA without symptoms |
| Self-management | Skin self-examination | Monthly, taught after diagnosis and reviewed each visit | Completed today | Taught today with a mirror and a handout: the palms, soles, between the toes and all nails, the sites people with darker skin most need to check, and the graft and both groins; he will photograph the graft each month |
| Self-management | Footwear and return to activity | After nail unit surgery | Completed today | Stiff-soled shoe until the graft has healed; running after it heals; football after the six-week graft check |
| Survey | Pain score | Each visit after surgery | Completed today | Worst pain 2 of 10, only after walking far |
| Survey | Depression screen (PHQ-2) | At each phase of care | Completed today | PHQ-2 score 0 |

## Goal progress

- Tissue diagnosis within two weeks of presentation. Outcome by 2026-06-17: Dermoscopy and nail matrix biopsy two days after presentation; diagnosis explained on the ninth day. **S**
- Definitive surgery with clear margins and lymph node staging within four weeks of diagnosis, by the approach he chose. Outcome by 2026-07-15: Digit-sparing excision of the nail unit with clear margins and a negative sentinel node two weeks after diagnosis. **S**
- Walk, run, and play football normally within four months of surgery. In progress; target 2026-10-19. **S**
- Monthly skin and nail self-examination, including the palms, soles, between the toes and all nails. In progress; target 2026-10-19. **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous, Version 3.2026 (2026), National Comprehensive Cancer Network
- Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019;80(1):208-250 (2019), American Academy of Dermatology
- Gershenwald JE, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67(6):472-492 (2017), American Cancer Society (CA: A Cancer Journal for Clinicians)
- Chouquet L, et al. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. J Clin Med 2025;14(17):5932 (2025), Journal of Clinical Medicine
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force

## Follow-up

- Graft check by the surgical team at six weeks. Preventive visit in about two months. Melanoma review about three months after surgery. **S**
- Next scheduled visit 2026-09-21: periodic adult preventive visit. **S**
